Asymptomatic HSV‑2 Shedding and Transmission – CDC Guideline Summary
Epidemiology of Asymptomatic Shedding
- In immunocompetent individuals with genital HSV‑2 infection, viral shedding occurs on approximately 2–3 % of days. 1
- Shedding is more frequent with genital HSV‑2 than with genital HSV‑1 infection. 1, 3
- Persons who acquired genital herpes within the past 12 months experience higher frequencies of asymptomatic shedding compared with those infected longer ago. 1, 3
Transmission Risk During Asymptomatic Periods
- ≈ 70 % of transmission events in HSV‑discordant couples occur while the infected partner is shedding without symptoms, making asymptomatic shedding the primary mechanism of spread. 2, 4, 5, 6
Counseling Recommendations
- All patients with genital herpes must be counseled that sexual transmission can occur during asymptomatic periods. 1, 2, 4, 3, 7
- Counseling should stress:
Suppressive Antiviral Therapy
- Daily suppressive therapy reduces—but does not eliminate—asymptomatic shedding. 3, 7, 9
- Valacyclovir 500 mg once daily lowered HSV‑2 transmission by ≈ 50 % in heterosexual discordant couples. 8
Recommended Suppressive Regimens (for patients concerned about transmission or with ≥ 6 recurrences per year)
| Regimen (dose & frequency) | Evidence |
|---|---|
| Acyclovir 400 mg orally twice daily | [3] |
| Famciclovir 250 mg orally twice daily | [3] |
| Valacyclovir 250–500 mg orally twice daily | [10] |
| Valacyclovir 1 000 mg orally once daily | [10] |
Note: Valacyclovir 500 mg once daily is less effective in patients with very frequent recurrences (≥ 10 episodes per year). 10, 9
Clinical Awareness
- The majority of individuals with genital HSV‑2 infection are unaware of their infection and lack a history of typical genital lesions. 10
- Asymptomatic partners should be asked about any history of typical or atypical genital lesions and encouraged to perform self‑examination for future lesions. 2, 10, 4, 5